Tag Archives: Treatment Action Group

WHO commemorates World Hepatitis Day in Egypt, where HCV infection rates are high, as are prices to critical medicines

By on .

It is a disease estimated to afflict more than 150 million people worldwide, infecting from three to four million more each year, and killing about 700,000. In Egypt, the World Health Organization estimates that 10 percent of people between 15 and 59 years old live with the disease. That’s hepatitis C alone. The combined impact […]

Ebola survivors in Sierra Leone, peer support and science in Zambia, and a groundbreaking activist group reflects on a year of challenges . . . We’re reading why affected community inclusion changes everything

By on .

CDC reports on Ebola survivors – As living proof that Ebola is not inevitably fatal, survivors of the current outbreak in West Africa have valuable stories to tell. With the possibility of some acquired immunity to the virus, they also may be better able than others to fill needed roles of caregivers and burial team […]

TAG’s TB drug guide aims to equip activists

By on .

While the impact of tuberculosis grew over the last decades of the 20th century, with drug resistant forms of the disease and HIV fueling its spread and slowing cures, the drugs used to treat TB have not changed. Bedaquiline and delaminid are the only new TB drugs to have been approved in over forty years, […]

Hepatitis resolution passed by 67th World Health Assembly includes calls for increased access to new medicine, syringe exchange

By on .

Committing the World Health Organization and member states of the United Nations to efforts to combat to hepatitis worldwide, the 67th World Health Assembly today passed a Hepatitis Resolution that includes calls to use legal flexibilities to lower prices of new effective medicines, and accelerate harm reduction programs for people who inject drugs. The resolution […]

TB drug approvals, distribution deal inches options forward, but MDR TB treatment access still uncertain where needed most

By on .

Last week’s developments in TB treatment included the announcement that bedaquiline, the currently most promising medicine for multi-drug-resistant tuberculosis, will become available to patients in 130 low- and middle-income countries through the Stop TB Partnership’s Global Drug Facility. That good news for multidrug-resistant TB patients, many of whom have run out of other options, was […]

TAG scrutinizes research, policy and prices, Paul Ryan eyes foreign aid, the Global Commission on Drug Policy highlights Hepatitis, and more . . . We’re reading pieces that deserve a second look

By on .

TAGline– Treatment Action Group takes a skeptical look at research and policy in its April Fools Day-released TAGline, highlighting issues, requiring “some degree of advocacy to remedy and ensure that the jokes don’t remain on us.” Among them, publicly funded research that leads to breakthroughs at private pharmaceutical companies that leads to high priced products, […]

TB treatment advocates to Sanofi pharmaceutical company on drug price: “We cry enough!”

By on .

A little more than four months ago, a collection of organizations and individuals concerned with the high price of rifapentine, a drug that could treat tuberculosis more quickly than other drugs, and also treat TB infection before it caused illness, wrote to Sanofi, the company that makes the medicine. Noting that government funding that had […]

Long road to effective TB treatment hits speed bumps: Regulatory refusal of one TB drug candidate, stalled progress on another

By on .

Momentum toward gathering an effective arsenal of treatment for tuberculosis may have gathered speed in recent years, the 2013 Pipeline Report jointly released by the Treatment Action Group and HIV i-base in June pointed out, yet it falls far short of what people sick and infected with TB worldwide need now. Case in point, the […]

Pipeline Report: Speed development of, access to products that will address global health needs

By on .

Imagine a world in which a single once-daily pill that can be taken without food, has few if any side effects, and can control the virus that leads to AIDS, is available, equally, to everyone who needs it. Imagine if governments and health systems all over the world were ready to make use of new […]

CDC report on U.S. TB drug shortage reflects local and global challenges

By on .

With no medicine on hand, a father and his infant who have just been diagnosed with multidrug-resistant tuberculosis go untreated, the delay prolonging their recoveries as well as the time they will remain infectious. The delay adds to the risk that they will get sicker and resistant to more drugs, increases the odds that those […]